Panacea Biotech Homepage >> Moneycontrol.com >> Stocks >> Panacea Biotech >> Pharmaceuticals >> Price/Quote, Highs, Lows, Volumes, Graphs, Bid, Offers, Historic Prices, Financials, Income, Results, Mutual Funds, Background, Management, News, Views, Actions, Interviews, Messages
| Panacea Biotech (BSE: 531349 | NSE: PANACEABIO | ISIN: INE922B01023) |
 |
390.00  -9.10 (-2.28%) |
| BSE : May 16, 15:53 |
|
| 385.75 -13.60 (-3.41%) |
| NSE : May 16, 15:36 |
|
| Open |
400.00 |
Vol |
60,183 |
| Prev. Close |
399.10 |
|
|
|
Intraday |
52 Week |
|
| Highs |
400.00 |
493.95 |
|
| Lows |
381.00 |
284.40 |
|
|
| Open |
400.00 |
Vol |
33,872 |
| Prev. Close |
399.35 |
|
|
|
Intraday |
52 Week |
|
| Highs |
400.00 |
499.90 |
|
| Lows |
383.00 |
0.00 |
|
|
|
BID |
OFFER |
| Price |
382.10 |
385.65 |
| Quantity |
30.00 |
50.00 |
|
|
BID |
OFFER |
| Price |
0.00 |
0.00 |
| Quantity |
0.00 |
0.00 |
|
| Mkt Cap |
2,606.87 |
| |
* P/E |
19.80 |
| |
Div |
100.00 |
| |
* EPS (TTM) |
19.70 |
| |
B/V: |
80.67 |
| Mkt Lot |
1.00 |
| |
FV |
1.00 |
| |
* EPS: As per stand alone adjusted profit after extra-ordinary items |
|
| Historic Prices & Returns of Panacea Biotech |
Compare Price Performance With Peers |
| Price |
1 week |
2 week |
1 month |
3 month |
6 month |
9 month |
1 year |
| BSE |
/ |
NSE |
| 397.30 |
396.70 |
378.00 |
301.45 |
354.00 |
376.70 |
417.30 |
| -1.84% |
-1.69% |
3.17% |
29.37% |
10.17% |
3.53% |
-6.54% |
| 397.15 |
397.30 |
378.05 |
300.55 |
351.60 |
375.55 |
415.70 |
| -2.87% |
-2.91% |
2.04% |
28.35% |
9.71% |
2.72% |
-7.2% |
|
Gain/Loss |
|
|
|
| This page Auto Refreshes every 5 minutes |
|
|
|
| |
|
|
|
|
|
| BSE/NSE Notices - Panacea Biotech |
| Panacea Biotec Ltd has informed BSE that the Company will be publishing the Audited Results for the Financial Year ended March 31, 2008 within three m |
| |
| more... |
| |
|
|
|
| Financials of Panacea Biotech |
Quarterly |
Annual
|
| Income Statement |
(Dec '07) |
(Mar '07) |
| Net Sales |
226.35 |
834.50 |
| Other Income |
0.62 |
26.46 |
| PBDIT |
59.60 |
250.69 |
| Net Profit |
28.93 |
146.81 |
|
|
|
| Balance Sheet |
| Total Share Capital |
6.58 |
| Net Worth |
539.09 |
| Total Debt |
213.42 |
| Net Block |
277.33 |
| Investments |
22.95 |
| Net Current Assets |
327.81 |
| Total Assets |
752.51 |
|
|
|
|
|
|
|
|
|
| Company Facts - Panacea Biotech |
|
|
|
| Registrars |
Skyline Financial Services (p) Ltd.
123, Vinoba Puri
Lajpat Nagar - II
|
| Tel : 29833777, 29847136, 30940462, 30950999 |
| Fax : 29848352 |
| Email : admin@skylinerta.com |
Website :
|
|
|
|
|
|
| Management - Panacea Biotech |
| |
| Soshil Kumar Jain Chairman / Chair Person |
| Ravinder Jain Managing Director |
| Rajesh Jain Joint Managing Director |
| Sandeep Jain Joint Managing Director |
| Sumit Jain Director (Operations) |
| R L Narasimhan Non Executive Director |
| N N Khamitkar Non Executive Director |
| Sunil Kapoor Non Executive Director |
| M L Kalra Non Executive Director |
| Gurmeet Singh Non Executive Director |
| K M Lal Non Executive Director |
| A N Saksena Non Executive Director |
| |
|
|
|
| Type |
| S Panacea Biotech |
| SMS to 52622 you |
| will receive the latest quote on both BSE & NSE. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Markets are volatile. Keep stock because every second counts.
Make moneycontrol.com your homepage now!.
Offline
